EGFRvIII expression is associated with shorter progression-free and overall survival in glioblastoma patients treated with standard-of-care temozolomide and radiation: A report from the RTOG-0525 trial.
Conference
Cahill, Daniel P, George, Asha, Gilbert, Mark R et al. (2013). EGFRvIII expression is associated with shorter progression-free and overall survival in glioblastoma patients treated with standard-of-care temozolomide and radiation: A report from the RTOG-0525 trial.
. MOLECULAR CANCER THERAPEUTICS, 12(11), 10.1158/1535-7163.TARG-13-A110
Cahill, Daniel P, George, Asha, Gilbert, Mark R et al. (2013). EGFRvIII expression is associated with shorter progression-free and overall survival in glioblastoma patients treated with standard-of-care temozolomide and radiation: A report from the RTOG-0525 trial.
. MOLECULAR CANCER THERAPEUTICS, 12(11), 10.1158/1535-7163.TARG-13-A110